Dr. Charlotte Hall completed her PhD in Forensic and Cognitive Psychology at the University of Lincoln in 2011. Her PhD investigated the potential use of gaze patterns as a measure of detecting sexual preference in forensic populations. Prior to this Charlotte worked as a research assistant on a number of projects, investigating diverse topics including psycholinguistics, child development, emotion, comparative cognition and forensic mental health. Charlotte joined the University of Nottingham through the NIHR- Collaborations for Leadership in Applied Health Research and Care (CLAHRC-NDL) in November 2011.
In her current role, Charlotte is Clinical Trial Manager and Senior Research Fellow as part of the MindTech team. Charlotte trial manages the ORBIT Trial, which is evaluating the remote digital intervention for tics. Charlotte is also a co-investigator on the FACT trial, assessing the use of the QbTest for young people in prison (led by Dr Chitsabesan at the University of Manchester), the QUOTA Trial assessing QbTest or medication management (led by Dr Maddie Groom at the University of Nottingham) and the SATURN trial which looks at medication for children with ADHD and tics (led by Prof Hollis). She was also the Trial manager on the AQUA Trial which investigated the clinical and cost-effectiveness of the QbTest, the findings of which are being implemented in routine practice. Charlotte is also leading on an NIHR CLAHRC systematic review investigating the clinical use of technology for children with neurodevelopmental disorders.
Charlotte's main areas of interest include the implementation of technology to support the assessment, monitoring and treatment of mental health disorders within children and young people, particularly in neurodevelopmental disorders. Charlotte has specific expertise of the design, conduct and management of clinical trials in community child mental health services and child and adolescent mental health services (CAMHS) and is interested in the nuances in online trail delivery.
Charlotte has a keen interest in how technology may be used to improve access to services and streamline current pathways and has experience in supporting adoption of technology in routine practice.
Continuous Performance Tests (CPT)
Randomised controlled trials
Charlotte is currently Trial Manager on the ORBIT-Trial. The aim of this study is to assess the clinical and cost-effectiveness of a remotely delivered therapist guided, parent assisted digital… read more
HALL, C.L., MOLDAVSKY, M., TAYLOR, J., SAYAL, K., MARRIOT, M., BATTY, M., PASS, S. and HOLLIS, C., 2014. Implementation of routine outcome measurement in Child and Adolescent Mental Health Services in the United Kingdom: a critical perspective. European Child & Adolescent Psychiatry. 23(4), 239-242 HALL, C.L., NEWELL, K., TAYLOR, J., SAYAL, K., SWIFT, K.D. and HOLLIS, C., 2013. 'Mind the gap' - Mapping services for young people with ADHD transitioning from child to adult mental health services. BMC Psychiatry. 13, 186 SWIFT, K.D., HALL, C.L., MARIMUTTU, V.J., REDSTONE, L., SAYAL, K. and HOLLIS, C., 2013. Transition to adult mental health services for young people with Attention Deficit/Hyperactivity Disorder (ADHD): A qualitative analysis of their experiences. BMC Psychiatry. 13, 74
HALL, C.L, HOGUE, T and GUO, K, 2012. Sexual cognitions guide viewing strategies to human figures Journal of Sex Research.
Charlotte is currently Trial Manager on the ORBIT-Trial. The aim of this study is to assess the clinical and cost-effectiveness of a remotely delivered therapist guided, parent assisted digital behavioural intervention (BiP TIC) for treating moderate and severe tics in children and adolescents with Tourette syndrome (TS) or chronic tic disorder (CTD). The trial is a single-blind parallel-group randomised, controlled, superiority trial of treatment as usual (TAU) + remote therapist-guided digital behavioural intervention (BiP TIC) compared to active control (TAU + remote online education and therapist support without BiP TIC), in children and young people (aged 9-17) with TS or CTD. The trial is recruiting nationally from CAMHS and community paediatrics, via the national charity Tourettes Action and from specialist Tourette's clinics in England. The intervention isbe delivered remotely from 2 regional centres in the Midlands/North (Queen's Medical Centre, Nottingham) and South of England (Great Ormond Street Hospital, London). There will be an initial internal pilot with strict 'stop-go' progression criteria to determine the acceptability of randomisation, adherence with the digital intervention and retention to follow-up.
Charlotte is also a co-investigator on the QUOTA study, which looks at the potential utility of a computerized cognitive test for ADHD, QbTest, to determine whether it can be a useful aid to medication management in ADHD
Charlotte also maintains her interest in general in investigating more objective measures for use in routine mental health (clinical and forensic) settings, particularly through through the use of technology.
My previous research extends across multiple disciplinary fields, but primarily lies in 'applied cognitive psychology'.
My PhD investigated the potential of gaze patterns as a measure to detect sexual preference. As part of this I was particularly interested in how gaze patterns may reflect previously reported differences in sexual arousal and interest in men and women. This research also investigated the link between subjective (i.e., self-report) and objective (gaze patterns) measures of sexual preference. Of primary interest to this research was the extent to which gaze patterns may be sensitive to deviant sexual preferences.
My previous post was lead researcher on the AQUA-Trial. The primary objective of this study is to assess whether providing clinicians and patients with the results of an objective test of activity and attention (QbTest) leads to earlier correct diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD). A secondary objective is to assess whether the QbTest leads to earlier optimisation of treatment and improved patient outcomes in ADHD in routine NHS settings. Together these findings assessed whether the QbTest can improve practice and patient outcome for children with ADHD, as well as its feasibility and acceptability and cost-effectiveness when added to routine healthcare settings. The findings have been published.